Home

Emcure Pharmaceuticals Ltd 52 Week High

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

YEARHIGH

₹ 1577.5

Last updated on: Feb 04, 2025

Key Highlights

  • The 52 Week HIGH of Emcure Pharmaceuticals Ltd is ₹ 1577 as of 04 Feb 25 .

Company Fundamentals for Emcure Pharmaceuticals Ltd

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Feb 20251253.9
03 Feb 20251247.45
01 Feb 20251248.65
31 Jan 20251229.05
30 Jan 20251219.75
29 Jan 20251211.3
28 Jan 20251170.75
27 Jan 20251224.9
24 Jan 20251285.2
23 Jan 20251355.3

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Emcure Pharmaceuticals Ltd News Hub

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs

Read more

13 Aug 24

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank

Read more

13 Aug 24

Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Emcure Pharmaceuticals to declare Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202

Read more

10 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Emcure Pharmaceuticals Ltd

What is the significance of Emcure Pharmaceuticals Ltd reaching its 52-week high?

Emcure Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Emcure Pharmaceuticals Ltd 52-week high?

Investors monitor Emcure Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Emcure Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Emcure Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Emcure Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Emcure Pharmaceuticals Ltd at its 52-week high?

Before investing in Emcure Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Emcure Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Emcure Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions